Literature DB >> 8478414

A region of the mouse genome homologous to human chromosome 1q21 affects facial clefting.

J Karolyi1, R P Erickson.   

Abstract

We sought to determine whether mouse chromosomal regions homologous to human chromosomal regions implicated in the etiology of facial clefting would be related to the incidence of spontaneous cleft palate (CP) or cleft lip with or without cleft palate [CL(P)], Dilantin-induced CL(P), hydrocortisone-induced CP, and/or 6-aminonicotinamide-induced CP. We found that a region on mouse chromosome 3, homologous to human chromosome 1q21, significantly increased the incidence of sporadic CL(P) when the allele from the A/J inbred strain was present. None of the other chromosomal regions or conditions studied had significant associations with this susceptibility to facial clefting, although there was a suggestion that the B allele of the same region was associated with hydrocortisone-induced CP. Thus, the region on human chromosome 1q21 should be further studied for a role in the etiology of human CL(P).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478414

Source DB:  PubMed          Journal:  J Craniofac Genet Dev Biol        ISSN: 0270-4145


  4 in total

1.  Genome scan for teratogen-induced clefting susceptibility loci in the mouse: evidence of both allelic and locus heterogeneity distinguishing cleft lip and cleft palate.

Authors:  S R Diehl; R P Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

2.  A human SHC-related sequence maps to chromosome 17, the SHC gene maps to chromosome 1.

Authors:  I G Yulug; S E Egan; C G See; E M Fisher
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

3.  Face facts: genes, environment, and clefts.

Authors:  J C Murray
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

4.  The major locus for multifactorial nonsyndromic cleft lip maps to mouse chromosome 11.

Authors:  D M Juriloff; D G Mah
Journal:  Mamm Genome       Date:  1995-02       Impact factor: 2.957

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.